A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT07489885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Study identification
- NCT ID
- NCT07489885
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- InventisBio Co., Ltd
- Industry
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- D-2570 Tablet Drug
- Placebo Tablets Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2026
- Primary completion
- Jul 31, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Jul 8, 2026
2026 – 2027
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Center | Birmingham | Alabama | 35244 | Recruiting |
| Study Center | Phoenix | Arizona | 85008 | Not yet recruiting |
| Study Center | Chula Vista | California | 91910 | Recruiting |
| Study Center | Fountain Valley | California | 92708 | Not yet recruiting |
| Study Center | Fremont | California | 94538 | Not yet recruiting |
| Study Center | Los Angeles | California | 90017 | Not yet recruiting |
| Study Center | Los Angeles | California | 90024 | Not yet recruiting |
| Study Center | San Diego | California | 92123 | Not yet recruiting |
| Study Center | Fort Lauderdale | Florida | 33308 | Not yet recruiting |
| Study Center | Miramar | Florida | 33027 | Not yet recruiting |
| Study Center | Ocala | Florida | 34470 | Not yet recruiting |
| Study Center | Tampa | Florida | 33607 | Not yet recruiting |
| Study Center | Sandy Springs | Georgia | 30328 | Not yet recruiting |
| Study Center | Savannah | Georgia | 31419 | Not yet recruiting |
| Study Center | Idaho Falls | Idaho | 83404 | Not yet recruiting |
| Study Center | Clarksville | Indiana | 40241 | Not yet recruiting |
| Study Center | Louisville | Kentucky | 40241 | Not yet recruiting |
| Study Center | Mayfield Heights | Ohio | 44124 | Not yet recruiting |
| Study Center | Philadelphia | Pennsylvania | 19103 | Not yet recruiting |
| Study Center | San Antonio | Texas | 78218 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07489885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07489885 live on ClinicalTrials.gov.